US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
US6441025B2
(en)
*
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
US8137684B2
(en)
*
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US20050163818A1
(en)
*
|
1996-11-05 |
2005-07-28 |
Hsing-Wen Sung |
Drug-eluting device chemically treated with genipin
|
US6867305B2
(en)
|
1996-12-03 |
2005-03-15 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6204388B1
(en)
*
|
1996-12-03 |
2001-03-20 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US20050043376A1
(en)
*
|
1996-12-03 |
2005-02-24 |
Danishefsky Samuel J. |
Synthesis of epothilones, intermediates thereto, analogues and uses thereof
|
DE69734362T2
(de)
*
|
1996-12-03 |
2006-07-20 |
Sloan-Kettering Institute For Cancer Research |
Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
CA2299608A1
(en)
*
|
1997-08-09 |
1999-02-18 |
Schering Aktiengesellschaft |
New epothilone derivatives, method for producing same and their pharmaceutical use
|
US7208010B2
(en)
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
US20040254635A1
(en)
|
1998-03-30 |
2004-12-16 |
Shanley John F. |
Expandable medical device for delivery of beneficial agent
|
US7713297B2
(en)
*
|
1998-04-11 |
2010-05-11 |
Boston Scientific Scimed, Inc. |
Drug-releasing stent with ceramic-containing layer
|
US20020099438A1
(en)
*
|
1998-04-15 |
2002-07-25 |
Furst Joseph G. |
Irradiated stent coating
|
US20030040790A1
(en)
*
|
1998-04-15 |
2003-02-27 |
Furst Joseph G. |
Stent coating
|
US7967855B2
(en)
*
|
1998-07-27 |
2011-06-28 |
Icon Interventional Systems, Inc. |
Coated medical device
|
US8070796B2
(en)
|
1998-07-27 |
2011-12-06 |
Icon Interventional Systems, Inc. |
Thrombosis inhibiting graft
|
CN1340053A
(zh)
*
|
1999-02-11 |
2002-03-13 |
舍林股份公司 |
依泊昔酮衍生物、其制备方法及药物用途
|
US20020058286A1
(en)
*
|
1999-02-24 |
2002-05-16 |
Danishefsky Samuel J. |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6716452B1
(en)
*
|
2000-08-22 |
2004-04-06 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US20040121954A1
(en)
*
|
1999-04-13 |
2004-06-24 |
Xu Wuhan Jingya |
Poly(dipeptide) as a drug carrier
|
AU772750C
(en)
*
|
1999-04-30 |
2005-02-24 |
Schering Aktiengesellschaft |
6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
|
AU7597000A
(en)
*
|
1999-09-21 |
2001-04-24 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Imaging of drug accumulation as a guide to antitumor therapy
|
WO2001026693A2
(en)
*
|
1999-10-12 |
2001-04-19 |
Cell Therapeutics, Inc. |
Manufacture of polyglutamate-therapeutic agent conjugates
|
US7067111B1
(en)
*
|
1999-10-25 |
2006-06-27 |
Board Of Regents, University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
AU1374601A
(en)
*
|
1999-11-12 |
2001-05-30 |
Angiotech International Ag |
Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
|
US20020077290A1
(en)
*
|
2000-03-17 |
2002-06-20 |
Rama Bhatt |
Polyglutamic acid-camptothecin conjugates and methods of preparation
|
CN1429121A
(zh)
*
|
2000-03-17 |
2003-07-09 |
细胞治疗公司 |
聚谷氨酸-喜树碱结合物及其制备方法
|
US8236048B2
(en)
|
2000-05-12 |
2012-08-07 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
GB0011903D0
(en)
*
|
2000-05-18 |
2000-07-05 |
Astrazeneca Ab |
Combination chemotherapy
|
DK1286704T3
(da)
|
2000-06-02 |
2014-09-22 |
Univ Texas |
Ethylendicystein (EC)-glucose analoge konjugater
|
DE60131537T2
(de)
|
2000-06-22 |
2008-10-23 |
Nitromed, Inc., Lexington |
Nitrosierte und nitrosylierte taxane, zubereitungen und methoden der verwendung
|
EP2080511A3
(de)
*
|
2000-08-22 |
2009-09-30 |
Shire LLC |
Aktivmittelzufuhrsysteme und Verfahren zum Schutz und zur Lieferung von Aktivmitteln
|
DE60124285T3
(de)
|
2000-09-29 |
2011-03-17 |
Cordis Corp., Miami Lakes |
Beschichtete medizinische geräte
|
US6764507B2
(en)
|
2000-10-16 |
2004-07-20 |
Conor Medsystems, Inc. |
Expandable medical device with improved spatial distribution
|
EP1582180B1
(de)
|
2000-10-16 |
2008-02-27 |
Conor Medsystems, Inc. |
Expandierbare medizinische Vorrichtung zum Zuführen eines Heilmittels
|
JP4583756B2
(ja)
|
2000-10-31 |
2010-11-17 |
クック インコーポレイテッド |
医療器具
|
US6612976B2
(en)
*
|
2000-11-13 |
2003-09-02 |
Isotech, L.L.C. |
Radioactive medical devices and methods of making radioactive medical devices
|
US6616592B1
(en)
*
|
2000-11-13 |
2003-09-09 |
Isotech, L.L.C. |
Radioactive medical devices for inhibiting a hyperplastic response and method of making radioactive medical devices
|
AU2001298033B2
(en)
*
|
2000-11-14 |
2007-08-09 |
Shire Llc |
A novel pharmaceutical compound containing abacavir sulfate and methods of making and using same
|
US8394813B2
(en)
|
2000-11-14 |
2013-03-12 |
Shire Llc |
Active agent delivery systems and methods for protecting and administering active agents
|
EP1401374B1
(de)
*
|
2000-11-14 |
2010-03-31 |
Shire LLC |
Neue pharmazeutische verbindung mit atenolol und verfahren zu ihrer herstellung und verwendung
|
EP1353667A1
(de)
|
2001-01-25 |
2003-10-22 |
Bristol-Myers Squibb Company |
Parenterale zusammensetzungen enthaltend epothilon-analoge
|
NZ526871A
(en)
*
|
2001-01-25 |
2006-01-27 |
Bristol Myers Squibb Co |
Pharmaceutical dosage forms of epothilones for oral administration
|
US20040073294A1
(en)
|
2002-09-20 |
2004-04-15 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
DE10115740A1
(de)
|
2001-03-26 |
2002-10-02 |
Ulrich Speck |
Zubereitung für die Restenoseprophylaxe
|
EP1389090A2
(de)
*
|
2001-04-26 |
2004-02-18 |
Board of Regents, The University of Texas System |
Diagnostische bildgebende zusammensetzungen, ihre syntheseverfahren und ihre verwendung
|
US20030108585A1
(en)
*
|
2001-05-04 |
2003-06-12 |
Roe R. Michael |
Polymer conjugates of insecticidal peptides or nucleic acids or insecticides and methods of use thereof
|
US8182527B2
(en)
|
2001-05-07 |
2012-05-22 |
Cordis Corporation |
Heparin barrier coating for controlled drug release
|
US7727221B2
(en)
|
2001-06-27 |
2010-06-01 |
Cardiac Pacemakers Inc. |
Method and device for electrochemical formation of therapeutic species in vivo
|
US7169752B2
(en)
*
|
2003-09-30 |
2007-01-30 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
US20050025808A1
(en)
*
|
2001-09-24 |
2005-02-03 |
Herrmann Robert A. |
Medical devices and methods for inhibiting smooth muscle cell proliferation
|
ES2625340T3
(es)
*
|
2001-10-15 |
2017-07-19 |
Crititech, Inc. |
Composiciones y métodos para la administración de fármacos escasamente solubles en agua y métodos de tratamiento
|
US7261875B2
(en)
*
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
US8877901B2
(en)
*
|
2002-12-13 |
2014-11-04 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
US8435529B2
(en)
*
|
2002-06-14 |
2013-05-07 |
Immunomedics, Inc. |
Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
|
US9770517B2
(en)
|
2002-03-01 |
2017-09-26 |
Immunomedics, Inc. |
Anti-Trop-2 antibody-drug conjugates and uses thereof
|
ITMI20020680A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
|
US20040022733A1
(en)
*
|
2002-07-31 |
2004-02-05 |
Uzgiris Egidijus E. |
Conjugated lysine copolymers
|
US8016881B2
(en)
|
2002-07-31 |
2011-09-13 |
Icon Interventional Systems, Inc. |
Sutures and surgical staples for anastamoses, wound closures, and surgical closures
|
US7649006B2
(en)
*
|
2002-08-23 |
2010-01-19 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
DE60330407D1
(de)
|
2002-08-23 |
2010-01-14 |
Sloan Kettering Inst Cancer |
Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
|
US6921769B2
(en)
|
2002-08-23 |
2005-07-26 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US20040047835A1
(en)
*
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
CN104383554B
(zh)
|
2002-09-06 |
2018-06-08 |
天蓝制药公司 |
用于传递治疗剂的以环糊精为基础的聚合物
|
DE10244847A1
(de)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
US20040166058A1
(en)
*
|
2002-11-07 |
2004-08-26 |
Board Of Regents, The University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
US20040142014A1
(en)
*
|
2002-11-08 |
2004-07-22 |
Conor Medsystems, Inc. |
Method and apparatus for reducing tissue damage after ischemic injury
|
US20040143321A1
(en)
*
|
2002-11-08 |
2004-07-22 |
Conor Medsystems, Inc. |
Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor
|
HUE040046T2
(hu)
|
2002-12-09 |
2019-02-28 |
Abraxis Bioscience Llc |
Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások
|
EP1572242B1
(de)
|
2002-12-13 |
2014-04-16 |
Immunomedics, Inc. |
Immun-conjugate mit einem intrazellular spaltbaren linker
|
US8420086B2
(en)
|
2002-12-13 |
2013-04-16 |
Immunomedics, Inc. |
Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
|
GB0305928D0
(en)
*
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
ATE526038T1
(de)
|
2003-03-28 |
2011-10-15 |
Innovational Holdings Llc |
Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle
|
US20070092440A1
(en)
*
|
2003-05-09 |
2007-04-26 |
Edgar Braendle |
Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial
|
EP1475105A1
(de)
*
|
2003-05-09 |
2004-11-10 |
Schering AG |
Knochengewebegerichtetes Radiopharmaceuticum und Tubulin-interagierende Verbindung kombinatorischer Radiotherapie
|
US7723311B2
(en)
*
|
2003-06-18 |
2010-05-25 |
Nanobiomagnetics, Inc. |
Delivery of bioactive substances to target cells
|
US8651113B2
(en)
*
|
2003-06-18 |
2014-02-18 |
Swr&D Inc. |
Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
|
US7344491B1
(en)
|
2003-11-26 |
2008-03-18 |
Nanobiomagnetics, Inc. |
Method and apparatus for improving hearing
|
US7229979B2
(en)
*
|
2003-06-23 |
2007-06-12 |
Immune Modulation, Inc. |
Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents
|
US20050152979A1
(en)
*
|
2003-09-05 |
2005-07-14 |
Cell Therapeutics, Inc. |
Hydrophobic drug compositions containing reconstitution enhancer
|
US7785653B2
(en)
|
2003-09-22 |
2010-08-31 |
Innovational Holdings Llc |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
US20050148534A1
(en)
*
|
2003-09-22 |
2005-07-07 |
Castellino Angelo J. |
Small molecule compositions and methods for increasing drug efficiency using compositions thereof
|
US9050378B2
(en)
*
|
2003-12-10 |
2015-06-09 |
Board Of Regents, The University Of Texas System |
N2S2 chelate-targeting ligand conjugates
|
WO2005079861A2
(en)
*
|
2004-02-13 |
2005-09-01 |
Safeway Investments Ltd. |
Polymeric water soluble prodrugs
|
US7317070B1
(en)
|
2004-03-12 |
2008-01-08 |
Sigma-Aldrich Co. |
Process for the preparation of polyamino acids
|
US7977373B2
(en)
|
2004-04-01 |
2011-07-12 |
Cardiome Pharma Corp. |
Prodrugs of ion channel modulating compounds and uses thereof
|
US7705036B2
(en)
*
|
2004-04-01 |
2010-04-27 |
Cardiome Pharma Corp. |
Deuterated aminocyclohexyl ether compounds and processes for preparing same
|
EP1729814A2
(de)
*
|
2004-04-01 |
2006-12-13 |
Cardiome Pharma Corp. |
Pegylierte ionenkanalmodulatoren
|
US8658203B2
(en)
|
2004-05-03 |
2014-02-25 |
Merrimack Pharmaceuticals, Inc. |
Liposomes useful for drug delivery to the brain
|
EP3173073A1
(de)
|
2004-05-03 |
2017-05-31 |
Merrimack Pharmaceuticals, Inc. |
Liposome zur arzneimittelverabreichung
|
EP1786433A4
(de)
*
|
2004-09-10 |
2008-02-27 |
Brij B Saxena |
Betulinol-derivate als anti-hiv-mittel
|
WO2006035340A1
(en)
*
|
2004-09-27 |
2006-04-06 |
Koninklijke Philips Electronics N.V. |
Method for selecting the sensitivity of an input device
|
WO2006042146A2
(en)
*
|
2004-10-07 |
2006-04-20 |
Emory University |
Multifunctional nanoparticles conjugates and their use
|
US20050148669A1
(en)
*
|
2004-10-21 |
2005-07-07 |
Daniel Amato |
Amino acid esters as nutrient supplements and methods of use
|
CN100361985C
(zh)
*
|
2004-10-26 |
2008-01-16 |
中国科学院长春应用化学研究所 |
可生物降解聚合物的紫杉醇前药及其合成方法
|
CA2586925C
(en)
|
2004-11-18 |
2016-06-07 |
Cardiome Pharma Corp. |
Synthetic process for aminocyclohexyl ether compounds
|
KR20070095916A
(ko)
*
|
2004-11-26 |
2007-10-01 |
스텐토믹스 인코포레이티드 |
의료용 임플란트에 킬레이트화 및 결합하는 화합물
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
EP1842557B1
(de)
|
2004-12-22 |
2013-10-23 |
Nitto Denko Corporation |
Arzneimittelträger und arzneimittelträgerkit zur hemmung von fibrose
|
US8377918B2
(en)
*
|
2005-01-31 |
2013-02-19 |
ACC Therapeutics Inc |
Apigenin for chemoprevention, and chemotherapy combined with therapeutic reagents
|
US7850645B2
(en)
*
|
2005-02-11 |
2010-12-14 |
Boston Scientific Scimed, Inc. |
Internal medical devices for delivery of therapeutic agent in conjunction with a source of electrical power
|
EP1853250B1
(de)
|
2005-02-18 |
2011-11-02 |
Abraxis BioScience, LLC |
Kombinationen und modi zur verabreichung therapeutischer mittel und kombinationstherapie
|
US8323333B2
(en)
*
|
2005-03-03 |
2012-12-04 |
Icon Medical Corp. |
Fragile structure protective coating
|
US20060200048A1
(en)
*
|
2005-03-03 |
2006-09-07 |
Icon Medical Corp. |
Removable sheath for device protection
|
US10058621B2
(en)
|
2015-06-25 |
2018-08-28 |
Immunomedics, Inc. |
Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers
|
US20060264914A1
(en)
*
|
2005-03-03 |
2006-11-23 |
Icon Medical Corp. |
Metal alloys for medical devices
|
US7540995B2
(en)
*
|
2005-03-03 |
2009-06-02 |
Icon Medical Corp. |
Process for forming an improved metal alloy stent
|
WO2006110197A2
(en)
*
|
2005-03-03 |
2006-10-19 |
Icon Medical Corp. |
Polymer biodegradable medical device
|
US7452502B2
(en)
*
|
2005-03-03 |
2008-11-18 |
Icon Medical Corp. |
Metal alloy for a stent
|
EP1858440B1
(de)
|
2005-03-03 |
2024-04-24 |
MiRus LLC |
Verbesserte metalllegierungen für ein medizinprodukt
|
US9107899B2
(en)
|
2005-03-03 |
2015-08-18 |
Icon Medical Corporation |
Metal alloys for medical devices
|
US20060201601A1
(en)
*
|
2005-03-03 |
2006-09-14 |
Icon Interventional Systems, Inc. |
Flexible markers
|
US9707302B2
(en)
|
2013-07-23 |
2017-07-18 |
Immunomedics, Inc. |
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
|
US9820986B2
(en)
*
|
2005-03-04 |
2017-11-21 |
Taiwan Hopaz Chems, Mfg. Co., Ltd. |
Glycopeptide compositions
|
US20060258736A1
(en)
*
|
2005-05-12 |
2006-11-16 |
Bristol-Myers Squibb Company |
Dosing regimen
|
EP1883627B1
(de)
|
2005-05-18 |
2018-04-18 |
Pharmascience Inc. |
An die bir-domäne bindende verbindungen
|
JP5159616B2
(ja)
|
2005-06-15 |
2013-03-06 |
カーディオム ファーマ コーポレイション |
アミノシクロヘキシルエーテル化合物の調製のための合成プロセス
|
WO2007008904A2
(en)
|
2005-07-08 |
2007-01-18 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Targeting poly-gamma-glutamic acid to treat staphylococcus epidermidis and related infections
|
ZA200802765B
(en)
*
|
2005-08-31 |
2009-08-26 |
Abraxis Bioscience Llc |
Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
|
NZ566705A
(en)
*
|
2005-08-31 |
2011-06-30 |
Abraxis Bioscience Llc |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
CA2622441A1
(en)
*
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
US7846445B2
(en)
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
US9839667B2
(en)
|
2005-10-14 |
2017-12-12 |
Allergan, Inc. |
Prevention and treatment of ocular side effects with a cyclosporin
|
US20070110786A1
(en)
*
|
2005-11-15 |
2007-05-17 |
Boston Scientific Scimed, Inc. |
Medical articles having enhanced therapeutic agent binding
|
EP1969031B1
(de)
|
2005-12-05 |
2009-06-03 |
Nitto Denko Corporation |
Polyglutamat-aminosäure-konjugate und verfahren
|
WO2007067498A1
(en)
*
|
2005-12-06 |
2007-06-14 |
Cell Therapeutics, Inc. |
Estrogen cancer therapy
|
US8906392B2
(en)
*
|
2005-12-16 |
2014-12-09 |
University Of Kansas |
Nanocluster compositions and methods
|
WO2010009146A1
(en)
*
|
2008-07-15 |
2010-01-21 |
University Of Kansas |
Nanoclusters for delivery of poorly water soluble drug nanoparticles
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
US20070148697A1
(en)
*
|
2005-12-27 |
2007-06-28 |
Boston Scientific Scimed, Inc. |
Methods and system for high throughput screening of polymer materials for medical devices
|
US8834912B2
(en)
*
|
2005-12-30 |
2014-09-16 |
Boston Scientific Scimed, Inc. |
Medical devices having multiple charged layers
|
US20070154466A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Jan Weber |
Internal medical devices containing peroxide-converting catalysts
|
US8840660B2
(en)
|
2006-01-05 |
2014-09-23 |
Boston Scientific Scimed, Inc. |
Bioerodible endoprostheses and methods of making the same
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
CN100431610C
(zh)
*
|
2006-01-24 |
2008-11-12 |
中国科学院长春应用化学研究所 |
两亲性三嵌段共聚物-紫杉醇键合药及其制备方法
|
US8440214B2
(en)
*
|
2006-01-31 |
2013-05-14 |
Boston Scientific Scimed, Inc. |
Medical devices for therapeutic agent delivery with polymeric regions that contain copolymers having both soft segments and uniform length hard segments
|
US8089029B2
(en)
|
2006-02-01 |
2012-01-03 |
Boston Scientific Scimed, Inc. |
Bioabsorbable metal medical device and method of manufacture
|
US20070225800A1
(en)
*
|
2006-03-24 |
2007-09-27 |
Sahatjian Ronald A |
Methods and devices having electrically actuatable surfaces
|
US20070224235A1
(en)
|
2006-03-24 |
2007-09-27 |
Barron Tenney |
Medical devices having nanoporous coatings for controlled therapeutic agent delivery
|
US8187620B2
(en)
|
2006-03-27 |
2012-05-29 |
Boston Scientific Scimed, Inc. |
Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
|
US8048150B2
(en)
|
2006-04-12 |
2011-11-01 |
Boston Scientific Scimed, Inc. |
Endoprosthesis having a fiber meshwork disposed thereon
|
US8758723B2
(en)
|
2006-04-19 |
2014-06-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for cellular imaging and therapy
|
BRPI0711591A2
(pt)
|
2006-05-16 |
2011-11-16 |
Aegera Therapeutics Inc |
composto de ligação de domìnio bir da iap
|
KR100773029B1
(ko)
*
|
2006-06-16 |
2007-11-05 |
이화여자대학교 산학협력단 |
수용성 미셀을 형성하는 생분해성 고리형 삼합체 포스파젠-탁솔 컨쥬게이트 항암제 및 이의 제조방법
|
US8815275B2
(en)
|
2006-06-28 |
2014-08-26 |
Boston Scientific Scimed, Inc. |
Coatings for medical devices comprising a therapeutic agent and a metallic material
|
JP2009542359A
(ja)
|
2006-06-29 |
2009-12-03 |
ボストン サイエンティフィック リミテッド |
選択的被覆部を備えた医療装置
|
US8052743B2
(en)
*
|
2006-08-02 |
2011-11-08 |
Boston Scientific Scimed, Inc. |
Endoprosthesis with three-dimensional disintegration control
|
EP2068757B1
(de)
|
2006-09-14 |
2011-05-11 |
Boston Scientific Limited |
Medizinprodukte mit wirkstofffreisetzender beschichtung
|
JP2010503491A
(ja)
|
2006-09-15 |
2010-02-04 |
ボストン サイエンティフィック リミテッド |
生物学的安定性無機層を有する生浸食性エンドプロスシーシス
|
EP2081616B1
(de)
|
2006-09-15 |
2017-11-01 |
Boston Scientific Scimed, Inc. |
Bioerodierbare endoprothesen und herstellungsverfahren dafür
|
EP2068782B1
(de)
|
2006-09-15 |
2011-07-27 |
Boston Scientific Limited |
Biologisch erodierbare endoprothesen
|
CA2663220A1
(en)
|
2006-09-15 |
2008-03-20 |
Boston Scientific Limited |
Medical devices and methods of making the same
|
WO2008034047A2
(en)
|
2006-09-15 |
2008-03-20 |
Boston Scientific Limited |
Endoprosthesis with adjustable surface features
|
US8002821B2
(en)
|
2006-09-18 |
2011-08-23 |
Boston Scientific Scimed, Inc. |
Bioerodible metallic ENDOPROSTHESES
|
JP2010503483A
(ja)
*
|
2006-09-18 |
2010-02-04 |
ボストン サイエンティフィック リミテッド |
医療装置
|
US10925977B2
(en)
|
2006-10-05 |
2021-02-23 |
Ceil>Point, LLC |
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
|
PT2724722T
(pt)
*
|
2006-10-20 |
2017-03-14 |
Neurendo Pharma Llc |
Método de restaurar o efeito incretina
|
US8173686B2
(en)
|
2006-11-06 |
2012-05-08 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
US8178564B2
(en)
*
|
2006-11-06 |
2012-05-15 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
US8168661B2
(en)
*
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
US8168662B1
(en)
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
US7981150B2
(en)
|
2006-11-09 |
2011-07-19 |
Boston Scientific Scimed, Inc. |
Endoprosthesis with coatings
|
US8998846B2
(en)
|
2006-11-20 |
2015-04-07 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US8414526B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
|
US8425459B2
(en)
|
2006-11-20 |
2013-04-23 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
|
US9737640B2
(en)
|
2006-11-20 |
2017-08-22 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8414525B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US9700704B2
(en)
|
2006-11-20 |
2017-07-11 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US8414909B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8414910B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US20080276935A1
(en)
|
2006-11-20 |
2008-11-13 |
Lixiao Wang |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
US8430055B2
(en)
|
2008-08-29 |
2013-04-30 |
Lutonix, Inc. |
Methods and apparatuses for coating balloon catheters
|
DE602007010669D1
(de)
|
2006-12-28 |
2010-12-30 |
Boston Scient Ltd |
Hren dafür
|
CN101209350B
(zh)
*
|
2006-12-30 |
2011-09-07 |
中国人民解放军军事医学科学院毒物药物研究所 |
以氨基酸为连接子的多聚谷氨酸-药物偶合物
|
WO2008089258A2
(en)
*
|
2007-01-16 |
2008-07-24 |
Cappella, Inc. |
Drug eluting medical device using polymeric therapeutics
|
US20080175881A1
(en)
*
|
2007-01-18 |
2008-07-24 |
Boston Scientific Scimed, Inc. |
Blood-contacting medical devices for the release of nitric oxide and anti-restenotic agents
|
US20080176958A1
(en)
|
2007-01-24 |
2008-07-24 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
US20080181852A1
(en)
*
|
2007-01-29 |
2008-07-31 |
Nitto Denko Corporation |
Multi-functional Drug Carriers
|
US20110033528A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Poniard Pharmaceuticals, Inc. |
Stabilized picoplatin oral dosage form
|
US8070797B2
(en)
|
2007-03-01 |
2011-12-06 |
Boston Scientific Scimed, Inc. |
Medical device with a porous surface for delivery of a therapeutic agent
|
US8431149B2
(en)
|
2007-03-01 |
2013-04-30 |
Boston Scientific Scimed, Inc. |
Coated medical devices for abluminal drug delivery
|
EP2139469A4
(de)
*
|
2007-03-19 |
2011-09-07 |
Inflabloc Pharmaceuticals Inc |
Cobalamintaxan-biokonjugate
|
TWI407971B
(zh)
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
US8067054B2
(en)
|
2007-04-05 |
2011-11-29 |
Boston Scientific Scimed, Inc. |
Stents with ceramic drug reservoir layer and methods of making and using the same
|
EP2144631A2
(de)
*
|
2007-04-10 |
2010-01-20 |
Nitto Denko Corporation |
Multifunktionale polyglutamat-wirkstoffträger
|
JP5341879B2
(ja)
|
2007-05-09 |
2013-11-13 |
日東電工株式会社 |
疎水性化合物及びポリアミノ酸複合体を含む組成物
|
DK2155254T3
(da)
*
|
2007-05-09 |
2013-03-04 |
Nitto Denko Corp |
Med platinlægemidler konjugerede polymere
|
JP2010526917A
(ja)
*
|
2007-05-09 |
2010-08-05 |
日東電工株式会社 |
複数種の薬物を有するポリグルタミン酸塩複合体及びポリグルタミン酸塩−アミノ酸複合体
|
US7976915B2
(en)
|
2007-05-23 |
2011-07-12 |
Boston Scientific Scimed, Inc. |
Endoprosthesis with select ceramic morphology
|
US20100260832A1
(en)
*
|
2007-06-27 |
2010-10-14 |
Poniard Pharmaceuticals, Inc. |
Combination therapy for ovarian cancer
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
US7942926B2
(en)
|
2007-07-11 |
2011-05-17 |
Boston Scientific Scimed, Inc. |
Endoprosthesis coating
|
US8002823B2
(en)
|
2007-07-11 |
2011-08-23 |
Boston Scientific Scimed, Inc. |
Endoprosthesis coating
|
CN101809024A
(zh)
*
|
2007-07-16 |
2010-08-18 |
铂雅制药公司 |
吡铂的口服制剂
|
JP2010533563A
(ja)
|
2007-07-19 |
2010-10-28 |
ボストン サイエンティフィック リミテッド |
吸着抑制表面を有する内部人工器官
|
US7931683B2
(en)
*
|
2007-07-27 |
2011-04-26 |
Boston Scientific Scimed, Inc. |
Articles having ceramic coated surfaces
|
US8815273B2
(en)
|
2007-07-27 |
2014-08-26 |
Boston Scientific Scimed, Inc. |
Drug eluting medical devices having porous layers
|
US8221822B2
(en)
|
2007-07-31 |
2012-07-17 |
Boston Scientific Scimed, Inc. |
Medical device coating by laser cladding
|
JP2010535541A
(ja)
|
2007-08-03 |
2010-11-25 |
ボストン サイエンティフィック リミテッド |
広い表面積を有する医療器具用のコーティング
|
AU2008287340A1
(en)
|
2007-08-15 |
2009-02-19 |
Amunix, Inc. |
Compositions and methods for modifying properties of biologically active polypeptides
|
US8052745B2
(en)
|
2007-09-13 |
2011-11-08 |
Boston Scientific Scimed, Inc. |
Endoprosthesis
|
US8003621B2
(en)
|
2007-09-14 |
2011-08-23 |
Nitto Denko Corporation |
Drug carriers
|
AR063111A1
(es)
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
JP5308447B2
(ja)
*
|
2007-10-16 |
2013-10-09 |
バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド |
C10−置換カンプトテシン類似体
|
US8216632B2
(en)
|
2007-11-02 |
2012-07-10 |
Boston Scientific Scimed, Inc. |
Endoprosthesis coating
|
US7938855B2
(en)
*
|
2007-11-02 |
2011-05-10 |
Boston Scientific Scimed, Inc. |
Deformable underlayer for stent
|
US8029554B2
(en)
|
2007-11-02 |
2011-10-04 |
Boston Scientific Scimed, Inc. |
Stent with embedded material
|
WO2009076272A2
(en)
*
|
2007-12-07 |
2009-06-18 |
Boston Scientific Scimed, Inc. |
Drug coated stent with endosome-disrupting conjugate
|
US8101706B2
(en)
|
2008-01-11 |
2012-01-24 |
Serina Therapeutics, Inc. |
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
|
CA2715348A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin and bevacizumab to treat colorectal cancer
|
CN102083468A
(zh)
*
|
2008-03-06 |
2011-06-01 |
日东电工株式会社 |
用于治疗癌症的聚合物紫杉醇结合物和方法
|
US8920491B2
(en)
|
2008-04-22 |
2014-12-30 |
Boston Scientific Scimed, Inc. |
Medical devices having a coating of inorganic material
|
US8932346B2
(en)
|
2008-04-24 |
2015-01-13 |
Boston Scientific Scimed, Inc. |
Medical devices having inorganic particle layers
|
US7998192B2
(en)
|
2008-05-09 |
2011-08-16 |
Boston Scientific Scimed, Inc. |
Endoprostheses
|
WO2009141823A2
(en)
|
2008-05-22 |
2009-11-26 |
Ramot At Tel Aviv University Ltd. |
Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
|
WO2009141827A2
(en)
|
2008-05-22 |
2009-11-26 |
Ramot At Tel Aviv University Ltd. |
A conjugate of a polymer, an anti-angiogenesis agent and a targeting moiety, and uses thereof in the treatment of bone related angiogenesis conditions
|
CN102105156B
(zh)
|
2008-05-22 |
2016-05-25 |
特拉维夫大学拉莫特有限公司 |
连接有治疗活性剂和血管生成靶向部分的聚合物的新型缀合物及其在治疗血管生成相关疾病中的用途
|
US20090297581A1
(en)
*
|
2008-05-28 |
2009-12-03 |
Boston Scientific Scimed, Inc. |
Medical devices having electrodeposited coatings
|
US8236046B2
(en)
*
|
2008-06-10 |
2012-08-07 |
Boston Scientific Scimed, Inc. |
Bioerodible endoprosthesis
|
US8449603B2
(en)
|
2008-06-18 |
2013-05-28 |
Boston Scientific Scimed, Inc. |
Endoprosthesis coating
|
EP2307069A2
(de)
*
|
2008-06-25 |
2011-04-13 |
Boston Scientific Scimed, Inc. |
Medizinische vorrichtungen zur abgabe eines therapeutischen mittels in verbindung mit galvanischer korrosion
|
WO2009158325A2
(en)
*
|
2008-06-25 |
2009-12-30 |
Boston Scientific Scimed, Inc. |
Medical devices having surface coatings
|
WO2009158489A2
(en)
*
|
2008-06-26 |
2009-12-30 |
Boston Scientific Scimed, Inc. |
Medical device coatings containing charged materials
|
WO2010014117A1
(en)
*
|
2008-07-30 |
2010-02-04 |
Nitto Denko Corporation |
Drug carriers
|
US7985252B2
(en)
|
2008-07-30 |
2011-07-26 |
Boston Scientific Scimed, Inc. |
Bioerodible endoprosthesis
|
US8399600B2
(en)
*
|
2008-08-07 |
2013-03-19 |
Sigma-Aldrich Co. Llc |
Preparation of low molecular weight polylysine and polyornithine in high yield
|
WO2010019645A2
(en)
|
2008-08-14 |
2010-02-18 |
Boston Scientific Scimed, Inc. |
Medical devices having electrodeposited conductive polymer coatings
|
US8382824B2
(en)
|
2008-10-03 |
2013-02-26 |
Boston Scientific Scimed, Inc. |
Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
|
US8231980B2
(en)
|
2008-12-03 |
2012-07-31 |
Boston Scientific Scimed, Inc. |
Medical implants including iridium oxide
|
PT2393828T
(pt)
|
2009-02-03 |
2017-01-18 |
Amunix Operating Inc |
Polipéptidos recombinantes estendidos e composições que compreendem os mesmos
|
US8703717B2
(en)
|
2009-02-03 |
2014-04-22 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
US8680050B2
(en)
|
2009-02-03 |
2014-03-25 |
Amunix Operating Inc. |
Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
|
EP2396036B1
(de)
|
2009-02-13 |
2017-06-28 |
Immunomedics, Inc. |
Immunokonjugate mit einer intrazellulär spaltbaren verknüpfung
|
WO2010101901A2
(en)
|
2009-03-02 |
2010-09-10 |
Boston Scientific Scimed, Inc. |
Self-buffering medical implants
|
US8071156B2
(en)
|
2009-03-04 |
2011-12-06 |
Boston Scientific Scimed, Inc. |
Endoprostheses
|
US8287937B2
(en)
|
2009-04-24 |
2012-10-16 |
Boston Scientific Scimed, Inc. |
Endoprosthese
|
US9849188B2
(en)
|
2009-06-08 |
2017-12-26 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
AU2010258898B8
(en)
|
2009-06-08 |
2015-02-05 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
JP5813641B2
(ja)
*
|
2009-08-24 |
2015-11-17 |
アムニクス オペレーティング インコーポレイテッド |
凝固第ix因子組成物ならびにそれを製造および使用する方法
|
US20120225825A1
(en)
*
|
2009-11-23 |
2012-09-06 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
EP2519269A1
(de)
|
2009-12-30 |
2012-11-07 |
Boston Scientific Scimed, Inc. |
Wirkstofffreisetzungsballons
|
CN103002919B
(zh)
*
|
2010-02-04 |
2015-03-25 |
得克萨斯系统大学评议会 |
纳米聚合物对免疫调节剂的肿瘤靶向递送
|
US8702682B2
(en)
*
|
2010-02-05 |
2014-04-22 |
Boston Scientific Scimed, Inc. |
Medical devices employing piezoelectric materials for delivery of therapeutic agents
|
EP2534170B1
(de)
|
2010-02-12 |
2017-04-19 |
Pharmascience Inc. |
Iap-bir-domänen bindende verbindungen
|
US8398916B2
(en)
|
2010-03-04 |
2013-03-19 |
Icon Medical Corp. |
Method for forming a tubular medical device
|
AR093275A1
(es)
|
2010-03-17 |
2015-05-27 |
Centro De Excelencia En Productos Y Procesos De Cordoba (Ceprocor) |
Una composicion farmaceutica soluble en agua que comprende al menos una sustancia terapeuticamente activa de caracteristicas hidrofobicas y al menos un compuesto seleccionado entre los sialoglicoesfingolipidos, los glicoesfingolipidos o una mezcla de sialoglicoesfingolipidos y glicoesfingolipidos
|
US8668732B2
(en)
|
2010-03-23 |
2014-03-11 |
Boston Scientific Scimed, Inc. |
Surface treated bioerodible metal endoprostheses
|
KR20130028728A
(ko)
|
2010-03-29 |
2013-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
암의 치료 방법
|
JP6242213B2
(ja)
|
2010-03-29 |
2017-12-06 |
アブラクシス バイオサイエンス, エルエルシー |
薬物送達および治療用薬剤の有効性を向上させる方法
|
WO2011123830A2
(en)
|
2010-04-02 |
2011-10-06 |
Amunix Operating Inc. |
Alpha 1-antitrypsin compositions and methods of making and using same
|
DE102010022588A1
(de)
|
2010-05-27 |
2011-12-01 |
Hemoteq Ag |
Ballonkatheter mit einer partikelfrei Wirkstoff-abgebenden Beschichtung
|
KR20180049180A
(ko)
|
2010-06-04 |
2018-05-10 |
아브락시스 바이오사이언스, 엘엘씨 |
췌장암의 치료 방법
|
WO2012153297A1
(en)
|
2011-05-11 |
2012-11-15 |
Ramot At Tel-Aviv University Ltd. |
Targeted polymeric conjugates and uses thereof
|
CN110151745A
(zh)
|
2011-12-13 |
2019-08-23 |
Io治疗公司 |
使用rxr激动剂的自身免疫紊乱的治疗
|
US9532972B2
(en)
|
2012-02-07 |
2017-01-03 |
University Of Central Florida Research Foundation, Inc. |
Increasing taxane sensitivity in cancer cells
|
HUE043537T2
(hu)
|
2012-02-15 |
2019-08-28 |
Bioverativ Therapeutics Inc |
Rekombináns VIII faktor fehérjék
|
PL3564260T3
(pl)
|
2012-02-15 |
2023-03-06 |
Bioverativ Therapeutics Inc. |
Kompozycje czynnika viii oraz sposoby ich wytwarzania i stosowania
|
US10172953B2
(en)
|
2012-02-27 |
2019-01-08 |
Amunix Operating Inc. |
XTEN conjugate compositions and methods of making same
|
WO2013131105A1
(en)
*
|
2012-03-02 |
2013-09-06 |
Sri International |
Synergistic anti-proliferation activity of tas-108 with mtor inhibitors against cancer cells
|
EP2822598A4
(de)
|
2012-03-05 |
2016-04-13 |
Univ Ramot |
Polymere mit daran konjugierten therapeutischen wirkstoffen, verfahren zur herstellung davon und verwendungen davon
|
CN102558270A
(zh)
*
|
2012-03-09 |
2012-07-11 |
辽宁新中现代医药有限公司 |
20(S) 和20(R)-达玛烷-3β,12β,20,25-四醇衍生物及其制备方法和应用
|
EP2801379B1
(de)
|
2012-03-27 |
2017-03-08 |
Terumo Kabushiki Kaisha |
Beschichtungszusammensetzung und medizinische vorrichtung
|
WO2013152227A1
(en)
*
|
2012-04-06 |
2013-10-10 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Embelin-based delivery system for water-insoluble active agents
|
RU2493848C1
(ru)
*
|
2012-06-14 |
2013-09-27 |
Геннадий Петрович Власов |
Биодеградируемый полимерный носитель для доставки противоопухолевого лекарственного средства (варианты)
|
US9382329B2
(en)
|
2012-08-14 |
2016-07-05 |
Ibc Pharmaceuticals, Inc. |
Disease therapy by inducing immune response to Trop-2 expressing cells
|
GB201215289D0
(en)
*
|
2012-08-28 |
2012-10-10 |
Medical Res Council |
Nanoparticle formulation
|
US20140094432A1
(en)
|
2012-10-02 |
2014-04-03 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
CN103808852A
(zh)
*
|
2012-11-15 |
2014-05-21 |
刘胜远 |
一种红豆杉中紫杉醇的薄层色谱检测方法
|
CN103641925B
(zh)
*
|
2012-11-27 |
2016-08-17 |
王晖 |
水溶性多聚糖与紫杉烷类化合物的共价聚化合物,其制备方法及医药用途
|
US10137196B2
(en)
|
2012-12-13 |
2018-11-27 |
Immunomedics, Inc. |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
|
US9931417B2
(en)
|
2012-12-13 |
2018-04-03 |
Immunomedics, Inc. |
Antibody-SN-38 immunoconjugates with a CL2A linker
|
KR102356017B1
(ko)
|
2012-12-13 |
2022-01-27 |
이뮤노메딕스, 인코오포레이티드 |
개선된 효능 및 감소된 독성을 위한 항체 및 sn-38의 면역컨쥬게이트의 투약
|
US9492566B2
(en)
|
2012-12-13 |
2016-11-15 |
Immunomedics, Inc. |
Antibody-drug conjugates and uses thereof
|
US10744129B2
(en)
|
2012-12-13 |
2020-08-18 |
Immunomedics, Inc. |
Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2
|
US10206918B2
(en)
|
2012-12-13 |
2019-02-19 |
Immunomedics, Inc. |
Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers
|
US10413539B2
(en)
|
2012-12-13 |
2019-09-17 |
Immunomedics, Inc. |
Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)
|
US9107960B2
(en)
|
2012-12-13 |
2015-08-18 |
Immunimedics, Inc. |
Antibody-SN-38 immunoconjugates with a CL2A linker
|
US11253606B2
(en)
|
2013-07-23 |
2022-02-22 |
Immunomedics, Inc. |
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, Bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
|
TW202003554A
(zh)
|
2013-08-14 |
2020-01-16 |
美商百歐維拉提夫治療公司 |
因子viii-xten融合物及其用途
|
US10300070B2
(en)
|
2014-03-27 |
2019-05-28 |
The Brigham And Women's Hospital, Inc. |
Metabolically-activated drug conjugates to overcome resistance in cancer therapy
|
CN106535826A
(zh)
|
2014-06-24 |
2017-03-22 |
怡康医疗股份有限公司 |
用于医疗装置的改进的金属合金
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
WO2015018380A2
(en)
|
2014-07-03 |
2015-02-12 |
Cspc Zhongqi Pharmaceutical Technology(Shijiazhuang)Co., Ltd. |
Therapeutic nanoparticles and the preparation methods thereof
|
KR101616623B1
(ko)
*
|
2014-07-24 |
2016-04-29 |
연세대학교 산학협력단 |
양이온성 고분자가 결합된 소수성 약물 및 음이온성 고분자가 결합된 친수성 약물을 포함하는 나노입자
|
CN107405343A
(zh)
|
2014-11-07 |
2017-11-28 |
明尼苏达大学董事会 |
可用于治疗疾病的盐和组合物
|
AR100034A1
(es)
|
2015-01-30 |
2016-09-07 |
Consejo Nac De Investig Científicas Y Técnicas (Conicet) |
Una composición farmacéutica soluble en agua que comprende, al menos, una sustancia terapéuticamente activa y, al menos, una sustancia con capacidad para formar micelas
|
CA2981543A1
(en)
|
2015-04-22 |
2016-10-27 |
Immunomedics, Inc. |
Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
|
US10195175B2
(en)
|
2015-06-25 |
2019-02-05 |
Immunomedics, Inc. |
Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors
|
BR112018002150A2
(pt)
|
2015-08-03 |
2018-09-18 |
Bioverativ Therapeutics Inc |
proteínas de fusão do fator ix e métodos de fabricação e uso das mesmas
|
KR20180038560A
(ko)
|
2015-08-28 |
2018-04-16 |
아뮤닉스 오퍼레이팅 인코포레이티드 |
키메라 폴리펩티드 조립체와 이의 제조 및 사용 방법
|
CN108366965B
(zh)
|
2015-10-16 |
2021-10-01 |
易普森生物制药有限公司 |
稳定喜树碱药物组合物
|
US11066465B2
(en)
|
2015-12-30 |
2021-07-20 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
CN108601841A
(zh)
|
2016-02-10 |
2018-09-28 |
免疫医疗公司 |
Abcg2抑制剂与sacituzumab govitecan(immu-132)的组合克服表达trop-2的癌中对sn-38的抗性
|
US11766506B2
(en)
|
2016-03-04 |
2023-09-26 |
Mirus Llc |
Stent device for spinal fusion
|
IL261669B2
(en)
|
2016-03-10 |
2023-12-01 |
Io Therapeutics Inc |
A combination of thyroid hormones and an RXR agonist for the treatment of autoimmune diseases
|
EP3695851B1
(de)
|
2016-03-14 |
2023-07-12 |
Wisconsin Alumni Research Foundation |
Oligolmilchsäurekonjugate und mizellen mit verbesserter antikrebswirkung
|
JP7379795B2
(ja)
|
2016-04-27 |
2023-11-15 |
イミューノメディクス、インコーポレイテッド |
チェックポイント阻害薬に再発/耐性を示す腫瘍を治療するための抗Trop-2-SN-38抗体薬物複合体の効果
|
SG10201609131YA
(en)
|
2016-11-01 |
2018-06-28 |
Xylonix Ip Holdings Pte Ltd |
Zinc-pga compositions and methods for treating cancer
|
WO2018087347A1
(en)
*
|
2016-11-14 |
2018-05-17 |
Karlsson-Tuner Invest As |
Use of non-transition metal coordinated dipyridoxyl compounds to prevent and treat chemotherapy-induced psn
|
EP3600283A4
(de)
|
2017-03-27 |
2020-12-16 |
Immunomedics, Inc. |
Behandlung von trop-2-exprimierendem triple-negativem brustkrebs mit sacituzumab govitecan und einem rad51-hemmer
|
US10799597B2
(en)
|
2017-04-03 |
2020-10-13 |
Immunomedics, Inc. |
Subcutaneous administration of antibody-drug conjugates for cancer therapy
|
IT201700067430A1
(it)
*
|
2017-06-16 |
2018-12-16 |
Consiglio Nazionale Ricerche |
Nanoparticelle quali veicoli di rilascio di principi attivi e metodi per la loro produzione
|
CA3076373A1
(en)
|
2017-09-20 |
2019-03-28 |
Io Therapeutics, Inc. |
Treatment of disease with esters of selective rxr agonists
|
US20200316213A1
(en)
*
|
2017-10-16 |
2020-10-08 |
The United States Of America, As Represented By The Secretary,Department Of Health And Human Servics |
Macromolecular platform for targeting scavenger receptor a1
|
WO2021072265A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
EP4069214A4
(de)
*
|
2019-12-03 |
2023-11-22 |
Onselex Pharmaceuticals, Inc. |
Polyphosphazen-arzneimittelträger
|
WO2022120147A1
(en)
*
|
2020-12-04 |
2022-06-09 |
The Methodist Hospital System |
Amino acid polymer-platinum anticancer drug conjugates
|
WO2023108012A1
(en)
|
2021-12-07 |
2023-06-15 |
Io Therapeutics, Inc. |
Use of an rxr agonist and taxanes in treating her2+ cancers
|